Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385202473> ?p ?o ?g. }
- W4385202473 abstract "Background Conflicting findings have been reported regarding the association between STK11/LKB1 mutations and immune checkpoint inhibitor (ICB) efficacy in NSCLC. It has been demonstrated that tumors could exhibit impaired STK11/LKB1 function even without STK11 mutations. We hypothesized that STK11 deficient phenotype rather than mutation may better stratify ICB outcomes. Methods Selected functional STK11 events and LKB1 protein data were leveraged to establish a transcriptomics-based classifier of STK11 phenotype (STK11 -deficient or -proficient). We analyzed in-house and Genentech/Roche’s data of three randomized trials of PD-(L)1 inhibition in NSCLC (ORIENT-11, N=171; OAK, N=699; POPLAR, N=192) and TCGA-NSCLC cohort. Results Tissue STK11 mutation did not affect ICB outcomes. However, the survival benefit of ICB versus chemotherapy lost or reversed in STK11-deficient tumors (HR for death, 95% CI: OAK [0.97, 0.69-1.35]; POPLAR [1.61, 0.88-2.97]; ORIENT-11 [1.07, 0.50-2.29]), while remaining in STK11-proficient tumors (HR for death, 95% CI: OAK [0.81, 0.66-0.99]; POPLAR [0.66, 0.46-0.95]; ORIENT-11 [0.59, 0.37-0.92]). In tumors differentially classified by phenotype and mutation status, STK11-WT/deficient tumors had significantly worse ICB outcomes than STK11-MUT/proficient tumors. The deleterious impact of STK11 deficiency was independent of STK11/KRAS/KEAP1 status or PD-L1 expression. The STING/IFN-I signaling, which was previously shown to be suppressed in STK11-MUT models, was perturbed in patients with STK11-deficient tumors but not in those with STK11-MUT tumors. Surprisingly, while high CD8+ T cell infiltration was significantly associated with prolonged survival with ICB in STK11-proficient tumors, it predicted an opposite trend towards worse ICB outcomes in STK11-deficient tumors across three trials. This suggested an association between STK11 deficiency and CD8+ T cell dysfunction which might not be reversed by PD-(L)1 blockade. Conclusions STK11 phenotype rather than mutation status can accurately distinguish ICB-refractory NSCLC patients and reflect immune suppression. It can help refine stratification algorithm for future clinical research and also provide a reliable resource aiding basic and translational studies in identifying therapeutic targets." @default.
- W4385202473 created "2023-07-25" @default.
- W4385202473 creator A5004580655 @default.
- W4385202473 creator A5009792917 @default.
- W4385202473 creator A5023899283 @default.
- W4385202473 creator A5029454312 @default.
- W4385202473 creator A5031597539 @default.
- W4385202473 creator A5046131158 @default.
- W4385202473 creator A5053008395 @default.
- W4385202473 creator A5054827762 @default.
- W4385202473 creator A5060293613 @default.
- W4385202473 creator A5061274135 @default.
- W4385202473 creator A5065418938 @default.
- W4385202473 creator A5066716873 @default.
- W4385202473 creator A5070121957 @default.
- W4385202473 creator A5080511731 @default.
- W4385202473 creator A5081726386 @default.
- W4385202473 creator A5081893862 @default.
- W4385202473 date "2023-07-01" @default.
- W4385202473 modified "2023-10-17" @default.
- W4385202473 title "STK11/LKB1-Deficient Phenotype Rather Than Mutation Diminishes Immunotherapy Efficacy and Represents STING/Type I Interferon/CD8+ T-Cell Dysfunction in NSCLC" @default.
- W4385202473 cites W1611944043 @default.
- W4385202473 cites W2044874695 @default.
- W4385202473 cites W2083855694 @default.
- W4385202473 cites W2129590156 @default.
- W4385202473 cites W2145411470 @default.
- W4385202473 cites W2159707944 @default.
- W4385202473 cites W2293531514 @default.
- W4385202473 cites W2559382297 @default.
- W4385202473 cites W2567564314 @default.
- W4385202473 cites W2741253009 @default.
- W4385202473 cites W2783897381 @default.
- W4385202473 cites W2796207838 @default.
- W4385202473 cites W2797429263 @default.
- W4385202473 cites W2803397860 @default.
- W4385202473 cites W2804812017 @default.
- W4385202473 cites W2886498337 @default.
- W4385202473 cites W2895058922 @default.
- W4385202473 cites W2898113652 @default.
- W4385202473 cites W2913235593 @default.
- W4385202473 cites W2913558101 @default.
- W4385202473 cites W2945998739 @default.
- W4385202473 cites W2952391626 @default.
- W4385202473 cites W2964315448 @default.
- W4385202473 cites W2965613730 @default.
- W4385202473 cites W2981543162 @default.
- W4385202473 cites W3006378317 @default.
- W4385202473 cites W3017125932 @default.
- W4385202473 cites W3024191006 @default.
- W4385202473 cites W3041397352 @default.
- W4385202473 cites W3047859155 @default.
- W4385202473 cites W3082530149 @default.
- W4385202473 cites W3092698750 @default.
- W4385202473 cites W3100907570 @default.
- W4385202473 cites W3111767567 @default.
- W4385202473 cites W3125772867 @default.
- W4385202473 cites W3136351248 @default.
- W4385202473 cites W3149961502 @default.
- W4385202473 cites W3178510225 @default.
- W4385202473 cites W3197121316 @default.
- W4385202473 cites W4200213413 @default.
- W4385202473 cites W4200468913 @default.
- W4385202473 cites W4213441758 @default.
- W4385202473 cites W4214876469 @default.
- W4385202473 cites W4283452496 @default.
- W4385202473 cites W4291020489 @default.
- W4385202473 cites W4293581698 @default.
- W4385202473 cites W4294944334 @default.
- W4385202473 cites W4296663392 @default.
- W4385202473 cites W4297229179 @default.
- W4385202473 cites W4306252020 @default.
- W4385202473 cites W4311576163 @default.
- W4385202473 cites W4316810205 @default.
- W4385202473 cites W4318041056 @default.
- W4385202473 cites W4319939127 @default.
- W4385202473 cites W4367301236 @default.
- W4385202473 doi "https://doi.org/10.1016/j.jtho.2023.07.020" @default.
- W4385202473 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37495171" @default.
- W4385202473 hasPublicationYear "2023" @default.
- W4385202473 type Work @default.
- W4385202473 citedByCount "0" @default.
- W4385202473 crossrefType "journal-article" @default.
- W4385202473 hasAuthorship W4385202473A5004580655 @default.
- W4385202473 hasAuthorship W4385202473A5009792917 @default.
- W4385202473 hasAuthorship W4385202473A5023899283 @default.
- W4385202473 hasAuthorship W4385202473A5029454312 @default.
- W4385202473 hasAuthorship W4385202473A5031597539 @default.
- W4385202473 hasAuthorship W4385202473A5046131158 @default.
- W4385202473 hasAuthorship W4385202473A5053008395 @default.
- W4385202473 hasAuthorship W4385202473A5054827762 @default.
- W4385202473 hasAuthorship W4385202473A5060293613 @default.
- W4385202473 hasAuthorship W4385202473A5061274135 @default.
- W4385202473 hasAuthorship W4385202473A5065418938 @default.
- W4385202473 hasAuthorship W4385202473A5066716873 @default.
- W4385202473 hasAuthorship W4385202473A5070121957 @default.
- W4385202473 hasAuthorship W4385202473A5080511731 @default.
- W4385202473 hasAuthorship W4385202473A5081726386 @default.
- W4385202473 hasAuthorship W4385202473A5081893862 @default.
- W4385202473 hasBestOaLocation W43852024731 @default.
- W4385202473 hasConcept C104317684 @default.